Form 4: Clover Health Exec's RSU Tax Withholding

Clover Health's CEO of Home Care, Brady Patrick Priest, reported the automatic withholding of 48,305 shares to cover tax obligations from RSU vesting.

Summary

• Brady Patrick Priest, CEO of Home Care at Clover Health Investments, Corp. (CLOV), reported a transaction involving Class A Common Stock.
• On October 18, 2025, 48,305 shares of Class A Common Stock were automatically withheld at a price of $2.71 per share.
• This withholding was to cover tax obligations upon the vesting of 6.25% of time-based restricted stock units (RSUs) originally granted on July 18, 2022.
• Following this transaction, Priest directly beneficially owns 2,340,274 shares of Class A Common Stock.
• The remaining RSUs are scheduled for a final vesting date on July 18, 2026, contingent on continued service.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction related to executive compensation (RSU vesting and tax withholding). It does not introduce new positive or negative information regarding the company's operations or financial health, thus maintaining a neutral sentiment.

Positives

• The transaction represents a routine vesting of previously granted equity compensation, indicating the executive's continued alignment with shareholder interests through long-term incentives.
• Brady Patrick Priest retains a significant direct beneficial ownership of 2,340,274 shares of Class A Common Stock after the tax withholding.

Negatives

• The disposal of shares, while for tax purposes, reduces the executive's direct share count by 48,305 shares.

Future Outlook

The remaining restricted stock units (RSUs) are scheduled for a final vesting date on July 18, 2026, subject to the reporting person's continued service.

Industry Context

This type of transaction, involving the automatic withholding of shares to cover tax liabilities upon the vesting of restricted stock units (RSUs), is a standard practice in executive compensation across various industries. It reflects the pre-scheduled realization of long-term equity incentives.

Comparison to Industry Standards

• This filing does not provide data points that allow for a direct comparison to specific comparable companies, projects, or results. The transaction is a routine insider compensation event.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary tax withholding event related to executive compensation. It confirms the ongoing vesting schedule of executive equity.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Final vesting of remaining restricted stock units (RSUs) on July 18, 2026, contingent on continued service.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary transaction by an insider (tax withholding upon RSU vesting). It does not provide any new material information that would alter the fundamental investment thesis for Clover Health. Therefore, a 'hold' recommendation is appropriate as there's no catalyst for a change in investment stance based solely on this filing.

Keywords

Clover Health, CLOV, Form 4, Insider Transaction, RSU Vesting, Tax Withholding, Brady Patrick Priest, CEO Home Care